Servier and Taiho Oncology, Inc., the release of data from SUNLIGHT, a pivotal Phase 3 global trial evaluating the combination of trifluridine/tipiracil (LONSURF®).
Canada Royal Enoch Phytomedicine Ltd., an innovative leader in ginseng and ginsenosides research and application, has the launch of a new clinical trial.
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, the availability, for in-office use, of Fortisite™ (compounded Tobramycin 1.5% + Vancomycin 5%) from its FDA‑registered and FDA‑inspected ImprimisRx® 503B outsourcing facility.
CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing.